Response assessment criteria and their applications in Lymphoma: Part 2

Mateen C. Moghbel, Erik Mittra, Andrea Gallamini, Ryan Niederkohr, Delphine L. Chen, Katherine Zukotynski, Helen Nadel, Lale Kostakoglu

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

Interim and end-of-Treatment PET/CT have become central to the evaluation of Hodgkin and non-Hodgkin lymphoma. This review article seeks to aid clinical decision making by providing an overview of available data on the diagnostic and prognostic value of PET/CT imaging for response assessment and pretransplant evaluation in lymphoma. The relative strengths and limitations of these techniques in various disease subtypes and clinical scenarios are explored, along with their current standards for reporting and latest developments. Particular attention is given to response-Adapted therapy, which is emerging as a cornerstone of clinical management.

Original languageEnglish (US)
Pages (from-to)13-22
Number of pages10
JournalJournal of Nuclear Medicine
Volume58
Issue number1
DOIs
Publication statusPublished - Jan 1 2017
Externally publishedYes

    Fingerprint

Keywords

  • Lymphoma
  • PET/CT response assessment
  • Responseadapted therapy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Moghbel, M. C., Mittra, E., Gallamini, A., Niederkohr, R., Chen, D. L., Zukotynski, K., ... Kostakoglu, L. (2017). Response assessment criteria and their applications in Lymphoma: Part 2. Journal of Nuclear Medicine, 58(1), 13-22. https://doi.org/10.2967/jnumed.116.184242